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The Peruvian Department of Loreto is the
last part of the greater Amazon region to report
the reemergence of epidemic malaria after the
eradication efforts of the 1960s. Loreto, which
comprises nearly one-fourth of the land mass of
Peru, has the ecologic characteristics of the
Amazon lowlands (Figure 1). In central Loreto,
the Marañon and Ucayali Rivers combine to form
the nascent Amazon River. Iquitos (population
345,000), the only large urban center in Loreto, is
accessible only by air or river. The rural
population of 474,000 is clustered in towns and
villages throughout the Amazon tributary
system. Loretos economy relies on basic
agriculture, fishing, lumber, commercial activi-
ties, and petroleum.
Epidemiology
Since 1941, the highest number of malaria
cases in Peru was 95,000 in 1944, and the lowest
was 1,500 cases in 1965 (after the malaria
eradication campaign) (1). Plasmodium
falciparum infections (chloroquine-sensitive)
were confined to the northwestern coastal areas
of Peru bordering Ecuador, with occasional
reports of cases from the north and eastern
Loreto border areas with Ecuador, Colombia,
and Brazil.
In 1988, no cases of P. falciparum were
reported in Loreto. In 1991, 140 cases were
reported; the number increased annually until
1997 when 54,290 slide-confirmed P. falciparum
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Epidemic malaria has rapidly emerged in Loreto Department, in the Peruvian
Amazon region. Peru reports the second highest number of malaria cases in South
America (after Brazil), most from Loreto. From 1992 to 1997, malaria increased 50-fold
in Loreto but only fourfold in Peru. Plasmodium falciparum infection, which has
increased at a faster rate than P. vivax infection in the last 3 years, became the dominant
Plasmodium infection in the highest transmission areas in the 1997 rainy season. The
vector Anopheles darlingi has also increased during this epidemic in Loreto. Moreover,
chloroquine and pyrimethamine-sulfadoxine drug-resistant P. falciparum strains have
emerged, which require development of efficacious focal drug treatment schemes.
Figure 1: The department of Loreto and the city of
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cases and 85 deaths were reported (Figure 2). In
1997, a total of 121,268 malaria cases were
reported in Loreto; the number indicates an
equally dramatic rise in P. vivax malaria.
P. malariae is infrequently reported (44 cases in
1997). An additional 36,864 persons were treated
for probable malaria (slide-negative or no
available laboratory diagnosis) in 1997. There-
fore, the number of malaria cases in 1997
reported by slide or clinical definition was
158,115 (2). More Plasmodium infections
occurred in males (60.5%) than in females
(39.5%). Malaria transmission has been seasonal
in the Loreto epidemic, with peaks in the rainy
season from November to June (Figure 3).
Malaria around the city of Iquitos accounts
for most cases in Loreto. Indigenous P. vivax
malaria was initially reported in the Iquitos area
(Rumococha and Zungarococha) in April 1991,
and P. falciparum was first detected (Padrecocha)
in November 1994. A small number of
P. falciparum cases have been diagnosed in
patients who had not traveled outside Iquitos in
the 2 months before illness. Entomologic
investigations have confirmed that malaria
transmission inside Iquitos is possible. Two high
transmission zones surround Iquitos: communi-
ties on the Nanay River (which empties into the
Amazon after bordering northern and eastern
Iquitos) and communities along the first asphalt
extension road from Iquitos (the unfinished
Iquitos-Nauta road). Two additional high
transmission zones include communities on the
Yavarí River and the Pastaza River. The annual
parasite index (number of malaria cases per
1,000 persons per year), with malaria transmis-
sion by districts in Loreto, is shown in Figure 4.
The global annual parasite index for Loreto for
1997 was 148 per 1,000 persons.
Age-specific attack rates of P. falciparum in
most of Loreto are consistent with hypoendemic
malaria (defined as parasite or spleen rates less
than 10% [Figure 5A]), although in 1997 in the
highest transmission areas, mesoendemic ma-
laria measurements were transiently docu-
mented in prevalence studies (11% to 50%
parasite rates) (3). The high parasitemia rates in
adults in Loreto emphasize the environmental
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Figure 2: Malaria incidence in Loreto, 1992-1997.
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Figure 3. Malaria (all species) incidence in Loreto, by
month, 19941997.
Figure 4: Annual parasite index in Loreto, by district
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risks for malaria infection to adults and the lack
of immunity in this epidemic. Age-specific death
rates have documented a substantial risk for
death among those under 5 years of age and
among those 60 years of age and older, although
the number of deaths in children under 5 years
declined in 1997 (Figure 5B). The death rate
from P. falciparum malaria has been decreas-
ing (from 1.8 to 1.3 per 1000) in the last 4 years
(1994 to 1997).
Because of the current epidemic, Peru
reports the second highest number of malaria
cases in South America (after Brazil)most from
Loreto (in 1997, Loreto reported 67.2% of the
malaria cases in Peru) (4). From 1992 to 1997,
malaria increased 50-fold in Loreto and fourfold
in Peru. In 1992, 1.6% of malaria cases in Peru
were due to P. falciparum; in 1997 (in Loreto),
44.8% of malaria cases were due to P. falciparum
(5,6).
Vector Dynamics
Paralleling the malaria epidemic has been an
increase in the highly competent and anthropo-
philic malaria vector, Anopheles darlingi, the
principal P. falciparum vector in the Brazilian
Amazon (7,8). An. darlingi was not found in the
Iquitos area in 1991 (9) when indigenous P. vivax
was detected but has now been found in all areas
of Loreto and even within Iquitos (10-12). The
abundance of An. darlingi, already established
when P. falciparum was first reported from the
peri-Iquitos area in 1994, is clearly linked to the
marked rise in P. falciparum transmission.
An. darlingi larvae habitats around Iquitos
include small pools on cleared land, fish
hatcheries, areas of poor sanitation, swamps,
and the edges of small rivers. An. darlingi in the
Iquitos area bite indoors or outdoors from dusk to
midnight, with a small dawn peak. An. darlingi
represent more than 90% of the anophelines in
the peri-Iquitos area in the rainy season; they
decrease but remain the major anopheline species
in the dry season.
An. benarrochi is the dominant malaria
vector in western Loreto, while An. triannulatus
is the dominant vector in eastern Loreto. Other
Anopheles species in Loreto known to be malaria
vectors are An. oswaldoi, An. nuneztovari, and
An. rangeli.
Climatic Associations
Loreto has a climate typical of the Amazon
region, with a rainy season from November to May
and a second precipitation peak in September in
the dry season. The El Niño phenomenon in 1997
extended the dry season in Loreto, but caused
torrential rains along coastal Peru.
The level of the Amazon River in Iquitos
varies 10 meters annually (from 108 to 118
meters above sea level); flooding is usual on the
smaller tributaries but infrequent on the main
Amazon River. The mean annual temperature is
28oC, the warmest months are September and
October, and the humidity is persistently higher
than 87% (2).
Climatic indexes of river level, rainfall,
temperature, and humidity at Iquitos were
analyzed to determine association with malaria
prevalence. The height of the Amazon River at
Iquitos depends on rainfall on the eastern side of
the Andes Mountains as well as precipitation in
Loreto. The height of the Amazon is related to
malaria prevalence; the highest river level
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Figure 5. A. Age-adjusted incidence rates for
Plasmodium falciparum malaria in Loreto, 1996-
1997. B. Age-adjusted death rates for Plasmodium
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precedes the malaria prevalence peak by 2
months, and the lowest level precedes the
malaria prevalence low by 2 months (Figure 6A).
Precipitation peaked twice in 1997: 3 months
before and the same month that malaria cases
reached their highest number (Figure 6B). The
mean temperature was 27°C to 29°C and was
inversely associated with malaria cases (Figure
6C). Relative humidity was 87% to 93% and was
not associated with malaria prevalence.
Drug Resistance and Drug Treatment
Clinical resistance of P. falciparum parasites
to chloroquine and to the combination antifolate
drug pyrimethamine-sulfadoxine is a growing
public health problem in Peru. In an epidemic
characterized by limited population immunity,
parasitologic resistance (persistence or reemer-
gence of parasites) inevitably leads to clinical
resistance (reemergence of malarial symptoms).
Multiple regional in vivo drug susceptibility
testing for chloroquine (10% to 70% resistance)
and pyrimethamine-sulfadoxine (10% to 63%
resistance) has documented significant focal
differences in resistance patterns (13-15). Three
P. falciparum strains have converged on Loreto
and Iquitos: (Brazilian-pyrimethamine-
sulfadoxine and chloroquine, complete resis-
tance; Loretanapyrimethamine-sulfadoxine,
variable resistance; chloroquine resistant; and
Pastazan/coastal-chloroquine susceptible). These
strains were likely introduced and disseminated
in different ways (e.g., routine travel, illegal
narcotrafficking), but the increased abundance
of An. darlingi in Loreto has allowed them to
thrive. The highest percentage of strains
resistant to multiple drugs (both chloroquine and
pyrimethamine-sulfadoxineresistant) have been
found in the border areas of Colonia Angamos on
the Yavarí River, communities on the Blanco
River, and in Santa Clara near Iquitos.
From July through November 1996, we
performed in Iquitos two prospective studies of
P. falciparum drug resistance in patients from
periurban and rural areas in Loreto. Twenty-
eight day in vivo drug susceptibility testing of
P. falciparum to pyrimethamine-sulfadoxine
was performed in 62 patients. The WHO in vitro
microtest method was used to evaluate
P. falciparum susceptibility to mefloquine,
chloroquine, pyrimethamine-sulfadoxine, and
quinine in pretreatment specimens from the
same patients (16). Results showed significant
pyrimethamine-sulfadoxine resistance in Loreto
(31% in vivo and 67% in vitro) and documented in
vitro resistance of chloroquine (78% resistance).
P. falciparum parasites were susceptible to
mefloquine and quinine (17).
Figure 6: Plasmodium falciparum malaria incidence
in Loreto. A. Average Amazon River level at Iquitos,
by month. B. Precipitation at Iquitos, by month.
C. Average temperature (°C) at Iquitos, by month.
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A recent study in Loreto showed that in vivo
resistance to pyrimethamine-sulfadoxine corre-
lated with specific point mutations in
P. falciparum dihydrofolate reductase at amino
acid positions 51, 108, and 164, and
dihydropteroate synthase mutations at positions
437, 540, and 581 (18). Further studies mapping
the molecular resistance patterns of P. falciparum
in Loreto are under way.
Malaria diagnosis and treatment are
provided free of charge by the National Malaria
Program. Focal treatment schemes have been
designed depending on the local resistance
patterns as documented by in vivo methods.
Depending on local efficacy, first-line treatment
of chloroquine, second-line of pyrimethamine-
sulfadoxine, or third-line of quinine with
clindamycin or tetracycline is administered
(Figure 7). In 1998, treatment with mefloquine
was initiated in selected communities with
tertiary treatment schemes. All treatment lines
include one dose of primaquine to eradicate
P. falciparum gametocytes.
Control Schemes
Control strategies used by the Loreto Public
Health Department and the National Malaria
Program have included source, chemical, and
biologic reduction strategies. Source reduction
has consisted of community participation in
identifying and filling in larval sites. Chemical
control includes the use of insecticides in spatial
fogging and domiciliary spraying and on bed
nets. Pyrethroids (e.g., cyfluthrin) are used for
fogging and domiciliary residual spraying. Since
1988, DDT has not been used in Loreto. An
important challenge is that many Amazonian
houses have open eaves and windows that allow
mosquitoes to enter and exit without touching
surfaces (except for a persons skin). An. darlingi
behavioral studies have not yet been performed
in Loreto to determine if the mosquitoes rest
inside or outside after feeding. Larvaciding is
performed with temephos (tetramethyl-
thiodiphenylene phosphorothioate) placed at the
surface of the larval breeding sites. Biologic
control has been investigated with Bacillus
sphaericus  and  thuringiensis  in larval breeding
pools. These bacteria have a short residual effect
of 7 to 15 days in Loreto and require optimal
conditions of shade for maximum efficacy.
Bed nets (mosquiteros) are ubiquitous in
Loreto because of the many biting mosquito
species. Local bed nets are made  principally of
cotton and sell for US$10 to $15. Insecticides
were used in 1997 in the form of spraying (with
cyfluthrin or deltamethrim) and impregnation
(with either permethrim or deltamethrim) (19).
Preliminary results show a decrease in malaria
prevalence where insecticide-treated bed nets
are in use.
Conclusions
Malaria began to reemerge in the upper
Pastaza River and eastern border areas of Loreto
in the early 1990s. P. falciparum exceeded
P. vivax infections in the early part of the Loreto
epidemic (1992-1993). The abundance of
An. darlingi starting in 1993 set the stage for
explosive growth of both P. falciparum and
P. vivax transmission, especially around Iquitos,
which had previously not been affected. The
increase in the number of malaria cases and the
erosion of P. vivax dominance over P. falciparum
occurred in spite of governmental interventions
(treatment schemes, fumigation, larviciding,
and domiciliary spraying). While P. vivax
infections decreased slightly from 1996 to 1997,
P. falciparum cases continued to increase by
60%. However, the rate of increase in total
malaria cases slowedfrom a factor of 2.23 from
1995 to 1996 to 1.19 in 1996 to 1997. The
predominance of malaria infection in men is
Figure 7: Initial Plasmodium falciparum malaria
treatment schemes in Loreto by district, 1998.
Treatment efficiency* (cases cured/cohort number x
100) and efficacy** (cases cured/[cases cured +
resistant cases] x 100) shown for each treatment
scheme region. Treatment schemes: Primary-
chloroquine; secondary-pyrimethamine-sulfadoxine;
tertiary-quinine.214 Emerging Infectious Diseases Vol. 5, No. 2, AprilJune 1999
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likely the result of occupational risks (e.g.,
working in recently cleared areas, logging, and
night fishing and hunting).
The death rate of epidemic P. falciparum in
Loreto appears to be low. The oft-quoted 1%
death rate for P. falciparum infection (3) has
been reduced seven times, perhaps because of
determined efforts at the regional and national
levels to provide rapid and appropriate
treatment in malarious areas. Future efforts are
planned to continue and expand coverage to
further reduce deaths due to P. falciparum.
Although positive correlations were found
between malaria transmission periods and
Amazon River level and rainfall, the negative
correlation with temperature may not be as
significant as in other areas where higher
temperatures are positively correlated with
malaria cases (20). The mean temperature in the
rainy season in Loreto is still within the optimal
range for anopheline development, and so the
observed temperature correlation may have
little biologic influence on malarial prevalence.
Analysis of environmental factors indicates
that the optimal timing of malaria control
activities in 1998 was 2 months before the rainy
season. Integrated malaria control activities
began in the dry season with the strategy to
intervene before high transmission season. In
1998, slide-documented malaria cases decreased
30.7% to 84,059, with P. vivax cases decreasing
15.3% to 56,710 and P. falciparum cases
decreasing 49.6% to 27,336. The longer dry
season in 1997, apparently caused by El Niño,
may have assisted the Loreto Public Health
Department and National Malaria Program
efforts to control malaria in 1998.
Danger exists for further expansion of
malaria in Loreto, especially through expansion
of An. darlingi (into areas where it is not yet the
dominant vector) and evolution of P. falciparum
drug resistance. Consequently, more malaria
control research is needed, particularly environ-
mental control program studies, Anopheles
behavioral studies, drug resistance testing, and
community bed net trials.
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